Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
What Makes Corbus Pharmaceuticals (CRBP) a Good Fit for 'Trend Investing'
09:51am, Friday, 15'th Mar 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, Corbus Pharmaceuticals (CRBP) could be a great choice. It is one of the several stocks that passed through our
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
08:00am, Tuesday, 12'th Mar 2024
NORWOOD, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio,
All Three of Our Analysts Agree
08:02pm, Friday, 08'th Mar 2024
Personalized health screening from a “smart toilet”
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
08:00am, Wednesday, 06'th Mar 2024
NORWOOD, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Of
Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer
08:00am, Wednesday, 28'th Feb 2024
NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, t
Another Huge Buffett Purchase Highlights Recent Insider Buying
08:53am, Monday, 12'th Feb 2024
The most notable of insider purchases in the past week or so is again legendary investor Warren Buffett boosting the Berkshire Hathaway stake in his favorite petroleum company.
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
09:50am, Tuesday, 06'th Feb 2024
NORWOOD, Mass., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Off
Insider Buying at These Biotechs Is Huge
12:09pm, Monday, 05'th Feb 2024
As January wound to a close, the most notable insider purchases were in biopharma companies, particularly those with initial or secondary offerings of stock.
Corbus Pharmaceuticals stock: An explosive 342% YTD surge
08:40am, Monday, 05'th Feb 2024
Shares of Corbus Pharmaceuticals NASDAQ: CRBP have already experienced a meteoric rise of over 300% year-to-date. This is thanks to fresh news released two Fridays ago, on January 26.
NORWOOD, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, t
Corbus Pharmaceuticals Announces Pricing of Public Offering
09:19am, Wednesday, 31'st Jan 2024
NORWOOD, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, t
Corbus Pharmaceuticals Announces Proposed Public Offering
06:55pm, Tuesday, 30'th Jan 2024
NORWOOD, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, t
Corbus Pharmaceuticals: Surging On The Back Of Great News, But I See Dark Clouds
02:17pm, Monday, 29'th Jan 2024
Corbus Pharmaceuticals has experienced a surge in stock price after positive clinical results for their antibody drug conjugate, CRB-701. CRBP is conducting phase 1 studies for CRB-701 in patients wit
Corbus Pharmaceuticals (CRBP) is up 250%: what's up with the stock?
07:18am, Monday, 29'th Jan 2024
The stock of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) closed up nearly 250% last week. The gains happened after favourable pharmaceutical news that saw the stock climb above $29.
Why Is Corbus Pharmaceuticals (CRBP) Stock Up 300% Today?
02:19pm, Friday, 26'th Jan 2024
Shares of little-known Corbus Pharmaceuticals (NASDAQ: CRBP ) are absolutely skyrocketing today. At the time of writing, CRBP stock is up more than 300%, as investors price in a key announcement from
